Sean O'Leary
Concepts (415)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 109 | 2024 | 1202 | 17.700 |
Why?
| Vaccines | 37 | 2024 | 375 | 10.610 |
Why?
| Papillomavirus Vaccines | 33 | 2024 | 222 | 8.400 |
Why?
| Influenza Vaccines | 37 | 2023 | 497 | 6.390 |
Why?
| Health Knowledge, Attitudes, Practice | 37 | 2023 | 1168 | 5.900 |
Why?
| Immunization | 25 | 2024 | 397 | 5.520 |
Why?
| Parents | 34 | 2023 | 1181 | 4.930 |
Why?
| Papillomavirus Infections | 20 | 2024 | 261 | 4.740 |
Why?
| Vaccination Refusal | 14 | 2022 | 69 | 4.720 |
Why?
| Obstetrics | 14 | 2022 | 146 | 4.670 |
Why?
| Immunization Programs | 13 | 2021 | 204 | 4.630 |
Why?
| Gynecology | 13 | 2022 | 163 | 4.280 |
Why?
| Motivational Interviewing | 10 | 2023 | 88 | 4.040 |
Why?
| Patient Acceptance of Health Care | 24 | 2022 | 675 | 3.820 |
Why?
| Influenza, Human | 20 | 2022 | 543 | 3.510 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 89 | 3.350 |
Why?
| Immunization Schedule | 21 | 2023 | 183 | 3.300 |
Why?
| Practice Patterns, Physicians' | 24 | 2021 | 1175 | 3.280 |
Why?
| Attitude of Health Personnel | 26 | 2021 | 970 | 3.150 |
Why?
| Pregnancy Complications, Infectious | 8 | 2023 | 285 | 3.040 |
Why?
| Clergy | 4 | 2020 | 12 | 2.660 |
Why?
| Advisory Committees | 16 | 2024 | 207 | 2.360 |
Why?
| Hepatitis B | 4 | 2023 | 51 | 2.240 |
Why?
| Pediatrics | 16 | 2021 | 982 | 2.090 |
Why?
| Colorado | 34 | 2024 | 4090 | 1.990 |
Why?
| Child | 65 | 2024 | 18401 | 1.980 |
Why?
| Viral Vaccines | 4 | 2024 | 88 | 1.980 |
Why?
| Humans | 183 | 2024 | 114045 | 1.980 |
Why?
| Health Communication | 4 | 2021 | 40 | 1.960 |
Why?
| Religion | 3 | 2020 | 64 | 1.960 |
Why?
| Health Personnel | 12 | 2022 | 569 | 1.910 |
Why?
| Vaccination Coverage | 8 | 2024 | 63 | 1.880 |
Why?
| Meningococcal Vaccines | 9 | 2023 | 48 | 1.870 |
Why?
| Whooping Cough | 6 | 2022 | 48 | 1.830 |
Why?
| Physicians, Primary Care | 11 | 2021 | 222 | 1.830 |
Why?
| Attitude to Health | 9 | 2020 | 398 | 1.790 |
Why?
| Pediatricians | 8 | 2022 | 122 | 1.730 |
Why?
| Pregnancy | 34 | 2024 | 5499 | 1.670 |
Why?
| United States | 50 | 2023 | 12137 | 1.630 |
Why?
| Infant | 40 | 2024 | 7943 | 1.550 |
Why?
| Female | 108 | 2024 | 59324 | 1.540 |
Why?
| Communication | 12 | 2023 | 734 | 1.480 |
Why?
| Social Media | 4 | 2021 | 131 | 1.420 |
Why?
| Pregnant Women | 8 | 2022 | 129 | 1.390 |
Why?
| Treatment Refusal | 5 | 2020 | 85 | 1.360 |
Why?
| Adolescent | 51 | 2024 | 17800 | 1.340 |
Why?
| Primary Health Care | 13 | 2021 | 1502 | 1.290 |
Why?
| Adult | 63 | 2023 | 30375 | 1.280 |
Why?
| Health Promotion | 5 | 2020 | 675 | 1.260 |
Why?
| Surveys and Questionnaires | 32 | 2024 | 4595 | 1.210 |
Why?
| Adolescent Health Services | 4 | 2015 | 68 | 1.200 |
Why?
| Physicians, Family | 10 | 2021 | 201 | 1.190 |
Why?
| Measles | 4 | 2022 | 38 | 1.070 |
Why?
| Prenatal Care | 2 | 2020 | 250 | 1.070 |
Why?
| Physicians | 11 | 2022 | 765 | 1.060 |
Why?
| Infectious Disease Transmission, Vertical | 4 | 2023 | 150 | 1.020 |
Why?
| Diphtheria | 4 | 2022 | 20 | 0.990 |
Why?
| Measles-Mumps-Rubella Vaccine | 3 | 2022 | 41 | 0.990 |
Why?
| Tetanus | 4 | 2022 | 25 | 0.990 |
Why?
| Patient Outcome Assessment | 2 | 2019 | 122 | 0.980 |
Why?
| Child, Preschool | 26 | 2024 | 9114 | 0.960 |
Why?
| Policy | 3 | 2020 | 137 | 0.940 |
Why?
| Health Care Surveys | 12 | 2021 | 541 | 0.940 |
Why?
| Male | 71 | 2024 | 55396 | 0.920 |
Why?
| Practice Guidelines as Topic | 11 | 2023 | 1381 | 0.910 |
Why?
| Ambulatory Care | 4 | 2020 | 479 | 0.880 |
Why?
| Physician-Patient Relations | 5 | 2020 | 459 | 0.850 |
Why?
| Pandemics | 5 | 2024 | 1310 | 0.830 |
Why?
| Religion and Medicine | 2 | 2019 | 25 | 0.820 |
Why?
| Reminder Systems | 4 | 2019 | 159 | 0.810 |
Why?
| Anterior Cruciate Ligament Reconstruction | 4 | 2022 | 114 | 0.810 |
Why?
| Hepatitis B Vaccines | 4 | 2023 | 46 | 0.770 |
Why?
| Trust | 2 | 2020 | 103 | 0.770 |
Why?
| Health Services Research | 4 | 2019 | 373 | 0.760 |
Why?
| Arthritis, Infectious | 1 | 2022 | 49 | 0.750 |
Why?
| Refusal to Treat | 2 | 2020 | 18 | 0.750 |
Why?
| Infant, Newborn | 14 | 2023 | 5038 | 0.750 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 159 | 0.740 |
Why?
| Middle Aged | 38 | 2023 | 26605 | 0.730 |
Why?
| Private Practice | 1 | 2020 | 20 | 0.720 |
Why?
| Standing Orders | 2 | 2020 | 11 | 0.710 |
Why?
| Pneumococcal Vaccines | 6 | 2021 | 131 | 0.710 |
Why?
| Preventive Health Services | 2 | 2020 | 134 | 0.710 |
Why?
| Professional-Patient Relations | 3 | 2018 | 140 | 0.710 |
Why?
| Osteomyelitis | 1 | 2022 | 105 | 0.700 |
Why?
| Cross-Sectional Studies | 11 | 2022 | 4402 | 0.690 |
Why?
| Myocarditis | 1 | 2021 | 93 | 0.680 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.680 |
Why?
| Stakeholder Participation | 1 | 2020 | 72 | 0.680 |
Why?
| Down Syndrome | 2 | 2021 | 335 | 0.680 |
Why?
| Text Messaging | 3 | 2019 | 152 | 0.670 |
Why?
| Health Care Costs | 3 | 2020 | 381 | 0.670 |
Why?
| Community Participation | 1 | 2020 | 112 | 0.670 |
Why?
| Safety-net Providers | 1 | 2021 | 96 | 0.660 |
Why?
| Freedom | 1 | 2019 | 12 | 0.660 |
Why?
| Young Adult | 20 | 2020 | 10444 | 0.660 |
Why?
| Schools | 2 | 2019 | 396 | 0.650 |
Why?
| Disease Outbreaks | 3 | 2022 | 305 | 0.650 |
Why?
| Chickenpox Vaccine | 3 | 2017 | 69 | 0.630 |
Why?
| Public Health | 3 | 2024 | 433 | 0.630 |
Why?
| Rural Population | 5 | 2022 | 443 | 0.630 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 138 | 0.620 |
Why?
| Mothers | 5 | 2022 | 650 | 0.610 |
Why?
| Information Seeking Behavior | 1 | 2018 | 35 | 0.600 |
Why?
| Patient Preference | 2 | 2017 | 164 | 0.590 |
Why?
| Rotavirus Vaccines | 2 | 2021 | 48 | 0.590 |
Why?
| Documentation | 2 | 2019 | 166 | 0.590 |
Why?
| Rotavirus Infections | 2 | 2021 | 50 | 0.590 |
Why?
| Urban Population | 3 | 2020 | 396 | 0.590 |
Why?
| Hepatitis A Vaccines | 4 | 2019 | 15 | 0.570 |
Why?
| Cues | 1 | 2019 | 301 | 0.560 |
Why?
| Physician's Role | 2 | 2019 | 192 | 0.540 |
Why?
| Mass Media | 1 | 2016 | 37 | 0.530 |
Why?
| Health Education | 2 | 2018 | 317 | 0.530 |
Why?
| Mumps | 3 | 2022 | 23 | 0.520 |
Why?
| Delivery of Health Care | 3 | 2023 | 828 | 0.520 |
Why?
| School Health Services | 3 | 2015 | 206 | 0.510 |
Why?
| Healthcare Disparities | 1 | 2021 | 479 | 0.500 |
Why?
| Vaccines, Combined | 4 | 2023 | 46 | 0.490 |
Why?
| Uterine Cervical Neoplasms | 1 | 2018 | 213 | 0.490 |
Why?
| Computers, Handheld | 1 | 2015 | 23 | 0.480 |
Why?
| Dengue Vaccines | 3 | 2019 | 9 | 0.460 |
Why?
| Anthrax Vaccines | 3 | 2018 | 7 | 0.460 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 6 | 0.460 |
Why?
| Qualitative Research | 7 | 2023 | 919 | 0.450 |
Why?
| Recovery of Function | 2 | 2020 | 573 | 0.450 |
Why?
| Hepatitis B Surface Antigens | 2 | 2023 | 18 | 0.440 |
Why?
| Internet | 5 | 2019 | 591 | 0.430 |
Why?
| Patient-Centered Care | 2 | 2015 | 470 | 0.420 |
Why?
| Seizures, Febrile | 1 | 2012 | 19 | 0.410 |
Why?
| Safety | 2 | 2020 | 298 | 0.400 |
Why?
| Respiratory Syncytial Virus Vaccines | 3 | 2023 | 24 | 0.400 |
Why?
| Meningococcal Infections | 3 | 2018 | 20 | 0.400 |
Why?
| Streptococcal Infections | 1 | 2014 | 127 | 0.400 |
Why?
| Nurseries, Hospital | 1 | 2012 | 4 | 0.390 |
Why?
| Herpes Zoster | 3 | 2022 | 330 | 0.390 |
Why?
| Age Factors | 6 | 2021 | 2885 | 0.390 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 12 | 0.390 |
Why?
| Georgia | 6 | 2021 | 62 | 0.390 |
Why?
| Family Practice | 7 | 2017 | 426 | 0.370 |
Why?
| Rotator Cuff | 3 | 2009 | 43 | 0.360 |
Why?
| Skin Diseases, Bacterial | 3 | 2016 | 22 | 0.360 |
Why?
| Mumps Vaccine | 3 | 2021 | 13 | 0.350 |
Why?
| Evidence-Based Medicine | 4 | 2020 | 662 | 0.350 |
Why?
| Pertussis Vaccine | 3 | 2022 | 21 | 0.350 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2023 | 97 | 0.340 |
Why?
| Attitude | 3 | 2021 | 228 | 0.340 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 1204 | 0.330 |
Why?
| Tenodesis | 1 | 2009 | 20 | 0.330 |
Why?
| Anterior Cruciate Ligament Injuries | 2 | 2022 | 130 | 0.330 |
Why?
| Aged | 16 | 2021 | 18969 | 0.320 |
Why?
| Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.320 |
Why?
| Retrospective Studies | 12 | 2023 | 12521 | 0.310 |
Why?
| Health Policy | 1 | 2012 | 330 | 0.310 |
Why?
| Vaccines, Contraceptive | 1 | 2008 | 1 | 0.310 |
Why?
| Egg Proteins | 1 | 2008 | 19 | 0.310 |
Why?
| Tendon Injuries | 1 | 2009 | 75 | 0.310 |
Why?
| Hepatitis B virus | 2 | 2023 | 25 | 0.310 |
Why?
| Guideline Adherence | 2 | 2013 | 489 | 0.310 |
Why?
| Ovulation | 1 | 2008 | 39 | 0.310 |
Why?
| Ovarian Follicle | 1 | 2008 | 61 | 0.300 |
Why?
| Societies, Medical | 4 | 2019 | 655 | 0.290 |
Why?
| Mobile Applications | 2 | 2020 | 140 | 0.290 |
Why?
| Cytomegalovirus | 1 | 2008 | 143 | 0.290 |
Why?
| Child Health | 2 | 2019 | 126 | 0.280 |
Why?
| Maternal Health Services | 2 | 2019 | 79 | 0.280 |
Why?
| Professional-Family Relations | 3 | 2018 | 131 | 0.280 |
Why?
| Respiratory Syncytial Viruses | 2 | 2023 | 46 | 0.270 |
Why?
| Logistic Models | 3 | 2021 | 1829 | 0.270 |
Why?
| Vaccines, Synthetic | 3 | 2022 | 124 | 0.270 |
Why?
| Cost-Benefit Analysis | 2 | 2020 | 544 | 0.270 |
Why?
| Receptors, Cell Surface | 1 | 2008 | 350 | 0.270 |
Why?
| Data Collection | 3 | 2014 | 618 | 0.260 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 429 | 0.260 |
Why?
| Shoulder Joint | 2 | 2008 | 158 | 0.250 |
Why?
| Time Factors | 4 | 2020 | 6077 | 0.240 |
Why?
| Patient Education as Topic | 2 | 2019 | 666 | 0.230 |
Why?
| Seasons | 2 | 2020 | 440 | 0.230 |
Why?
| Decision Making | 3 | 2020 | 760 | 0.230 |
Why?
| Home Health Aides | 1 | 2023 | 5 | 0.220 |
Why?
| Blood Coagulation Tests | 1 | 2023 | 51 | 0.220 |
Why?
| Bacterial Vaccines | 1 | 2024 | 61 | 0.220 |
Why?
| Hospitals | 3 | 2023 | 581 | 0.210 |
Why?
| Gout | 1 | 2003 | 36 | 0.210 |
Why?
| Hospitalization | 7 | 2023 | 1762 | 0.200 |
Why?
| Rubella | 1 | 2022 | 21 | 0.200 |
Why?
| Intention | 2 | 2020 | 142 | 0.190 |
Why?
| Infant Health | 1 | 2022 | 21 | 0.190 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.190 |
Why?
| Anti-Bacterial Agents | 3 | 2016 | 1471 | 0.190 |
Why?
| Knee Injuries | 1 | 2022 | 88 | 0.190 |
Why?
| Clinical Competence | 2 | 2018 | 882 | 0.190 |
Why?
| Russia | 1 | 2021 | 9 | 0.190 |
Why?
| Germany | 1 | 2021 | 84 | 0.190 |
Why?
| Complementary Therapies | 1 | 2022 | 74 | 0.180 |
Why?
| Risk | 2 | 2015 | 810 | 0.180 |
Why?
| Yellow Fever Vaccine | 2 | 2017 | 6 | 0.180 |
Why?
| Aged, 80 and over | 5 | 2020 | 6306 | 0.180 |
Why?
| Regression Analysis | 2 | 2020 | 945 | 0.180 |
Why?
| Hospital Rapid Response Team | 1 | 2021 | 15 | 0.180 |
Why?
| Demography | 2 | 2024 | 258 | 0.180 |
Why?
| Internal Medicine | 2 | 2014 | 211 | 0.180 |
Why?
| General Practitioners | 1 | 2021 | 23 | 0.180 |
Why?
| Antiviral Agents | 2 | 2023 | 642 | 0.180 |
Why?
| Cluster Analysis | 2 | 2022 | 452 | 0.180 |
Why?
| Washington | 1 | 2020 | 134 | 0.170 |
Why?
| Measles Vaccine | 1 | 2019 | 17 | 0.170 |
Why?
| Drug Storage | 1 | 2020 | 57 | 0.170 |
Why?
| Fever | 1 | 2021 | 280 | 0.170 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| Eligibility Determination | 1 | 2020 | 59 | 0.170 |
Why?
| Motivation | 1 | 2024 | 488 | 0.170 |
Why?
| Personnel Staffing and Scheduling | 1 | 2020 | 79 | 0.170 |
Why?
| Pennsylvania | 1 | 2019 | 94 | 0.160 |
Why?
| Reimbursement Mechanisms | 1 | 2020 | 76 | 0.160 |
Why?
| Medicaid | 2 | 2021 | 404 | 0.160 |
Why?
| State Government | 1 | 2019 | 41 | 0.160 |
Why?
| Government Regulation | 1 | 2019 | 46 | 0.160 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 88 | 0.160 |
Why?
| Europe | 1 | 2020 | 332 | 0.160 |
Why?
| Gastroenteritis | 1 | 2020 | 65 | 0.160 |
Why?
| Morbidity | 1 | 2020 | 277 | 0.160 |
Why?
| Therapeutic Uses | 1 | 2018 | 1 | 0.160 |
Why?
| Pulmonary Alveoli | 1 | 2021 | 372 | 0.150 |
Why?
| Quality Improvement | 3 | 2020 | 944 | 0.150 |
Why?
| Community-Based Participatory Research | 1 | 2019 | 130 | 0.150 |
Why?
| Urban Health Services | 1 | 2018 | 60 | 0.150 |
Why?
| Evidence-Based Practice | 2 | 2020 | 185 | 0.150 |
Why?
| Education, Continuing | 1 | 2018 | 39 | 0.150 |
Why?
| Nuclear Family | 1 | 2018 | 48 | 0.150 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 212 | 0.150 |
Why?
| Rural Health Services | 1 | 2018 | 92 | 0.150 |
Why?
| Guatemala | 4 | 2020 | 267 | 0.150 |
Why?
| Altitude | 1 | 2021 | 435 | 0.140 |
Why?
| Hemorrhage | 1 | 2021 | 600 | 0.140 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 68 | 0.140 |
Why?
| Cervical Plexus | 1 | 1997 | 1 | 0.140 |
Why?
| Adaptation, Psychological | 2 | 2020 | 545 | 0.140 |
Why?
| Mass Screening | 1 | 2023 | 979 | 0.140 |
Why?
| Spinal Nerve Roots | 1 | 1997 | 27 | 0.140 |
Why?
| Curriculum | 1 | 2023 | 813 | 0.140 |
Why?
| Pneumococcal Infections | 1 | 2018 | 91 | 0.140 |
Why?
| Multivariate Analysis | 1 | 2020 | 1422 | 0.140 |
Why?
| Travel | 1 | 2017 | 121 | 0.140 |
Why?
| Cost of Illness | 2 | 2018 | 254 | 0.140 |
Why?
| Behavior Therapy | 1 | 2019 | 225 | 0.140 |
Why?
| Administrative Personnel | 1 | 2016 | 29 | 0.130 |
Why?
| Focus Groups | 5 | 2018 | 378 | 0.130 |
Why?
| Leadership | 1 | 2019 | 291 | 0.130 |
Why?
| Allied Health Personnel | 1 | 2016 | 42 | 0.130 |
Why?
| Incidence | 2 | 2020 | 2314 | 0.130 |
Why?
| Physician Executives | 1 | 2016 | 33 | 0.130 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 59 | 0.130 |
Why?
| Zika Virus Infection | 1 | 2017 | 85 | 0.130 |
Why?
| Public Health Practice | 1 | 2016 | 61 | 0.130 |
Why?
| Minority Groups | 1 | 2018 | 223 | 0.130 |
Why?
| Patient Participation | 1 | 2019 | 348 | 0.130 |
Why?
| Diphtheria Toxoid | 1 | 2015 | 12 | 0.130 |
Why?
| Postpartum Period | 1 | 2018 | 275 | 0.130 |
Why?
| Cooperative Behavior | 3 | 2014 | 376 | 0.130 |
Why?
| Tetanus Toxoid | 1 | 2015 | 37 | 0.130 |
Why?
| Information Dissemination | 1 | 2017 | 185 | 0.130 |
Why?
| Intention to Treat Analysis | 1 | 2015 | 69 | 0.130 |
Why?
| Herpesvirus 3, Human | 1 | 2019 | 377 | 0.130 |
Why?
| Equipment and Supplies | 1 | 2015 | 38 | 0.130 |
Why?
| California | 1 | 2016 | 351 | 0.120 |
Why?
| Pre-Exposure Prophylaxis | 1 | 2017 | 179 | 0.120 |
Why?
| Prevalence | 1 | 2021 | 2247 | 0.120 |
Why?
| Lung Diseases | 1 | 2021 | 690 | 0.120 |
Why?
| Prospective Studies | 3 | 2021 | 6195 | 0.120 |
Why?
| Neck Pain | 1 | 2014 | 24 | 0.120 |
Why?
| Occupational Health Services | 1 | 2014 | 31 | 0.120 |
Why?
| Anterior Cruciate Ligament | 1 | 2015 | 79 | 0.120 |
Why?
| Nurses | 1 | 2016 | 145 | 0.120 |
Why?
| Poverty | 1 | 2018 | 440 | 0.120 |
Why?
| Sexual Behavior | 1 | 2018 | 434 | 0.110 |
Why?
| Public Health Administration | 1 | 2014 | 75 | 0.110 |
Why?
| Clinical Decision-Making | 3 | 2021 | 268 | 0.110 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.110 |
Why?
| Adolescent Behavior | 1 | 2018 | 486 | 0.110 |
Why?
| Social Behavior | 1 | 2015 | 267 | 0.110 |
Why?
| Intussusception | 1 | 2013 | 28 | 0.100 |
Why?
| Health Services Accessibility | 1 | 2019 | 756 | 0.100 |
Why?
| Parent-Child Relations | 1 | 2015 | 235 | 0.100 |
Why?
| Follow-Up Studies | 3 | 2020 | 4392 | 0.100 |
Why?
| Workplace | 1 | 2014 | 221 | 0.100 |
Why?
| Drug Contamination | 1 | 2013 | 51 | 0.100 |
Why?
| Electronic Health Records | 1 | 2019 | 799 | 0.100 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.100 |
Why?
| Risk Factors | 4 | 2023 | 8614 | 0.100 |
Why?
| Patient Compliance | 1 | 2016 | 524 | 0.100 |
Why?
| Outpatients | 1 | 2015 | 325 | 0.100 |
Why?
| Neisseria meningitidis | 1 | 2011 | 18 | 0.100 |
Why?
| Professional Practice Location | 1 | 2011 | 26 | 0.100 |
Why?
| Perinatal Care | 1 | 2012 | 36 | 0.100 |
Why?
| Community-Institutional Relations | 1 | 2012 | 89 | 0.100 |
Why?
| United Kingdom | 3 | 2020 | 226 | 0.090 |
Why?
| Cognition | 1 | 2018 | 990 | 0.090 |
Why?
| Pneumonia, Pneumococcal | 1 | 2010 | 38 | 0.090 |
Why?
| Swine | 1 | 2013 | 687 | 0.090 |
Why?
| Pain Measurement | 1 | 2012 | 441 | 0.090 |
Why?
| Sports | 1 | 2012 | 187 | 0.090 |
Why?
| Hospices | 1 | 2011 | 83 | 0.080 |
Why?
| Activities of Daily Living | 1 | 2012 | 348 | 0.080 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 89 | 0.080 |
Why?
| Interviews as Topic | 2 | 2023 | 575 | 0.080 |
Why?
| Communicable Diseases | 2 | 2022 | 127 | 0.080 |
Why?
| Rotator Cuff Injuries | 1 | 2009 | 53 | 0.080 |
Why?
| Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.080 |
Why?
| Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.080 |
Why?
| Connexin 43 | 1 | 2008 | 23 | 0.080 |
Why?
| Infertility, Female | 1 | 2008 | 93 | 0.070 |
Why?
| Registries | 1 | 2015 | 1764 | 0.070 |
Why?
| Appointments and Schedules | 2 | 2019 | 70 | 0.070 |
Why?
| Embryonic Development | 1 | 2008 | 117 | 0.070 |
Why?
| Leukocytes | 1 | 2008 | 272 | 0.070 |
Why?
| Quality of Life | 2 | 2020 | 2343 | 0.070 |
Why?
| Cell Phone | 2 | 2019 | 76 | 0.070 |
Why?
| Tendons | 1 | 2008 | 118 | 0.070 |
Why?
| Ovary | 1 | 2008 | 190 | 0.070 |
Why?
| Health Surveys | 2 | 2018 | 441 | 0.060 |
Why?
| Cohort Studies | 2 | 2014 | 4883 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2008 | 1144 | 0.060 |
Why?
| Fetal Development | 1 | 2008 | 248 | 0.060 |
Why?
| Algorithms | 2 | 2023 | 1469 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2008 | 465 | 0.060 |
Why?
| Treatment Outcome | 4 | 2022 | 9049 | 0.060 |
Why?
| Immobilization | 1 | 2004 | 42 | 0.060 |
Why?
| Neoplasms | 1 | 2018 | 2086 | 0.060 |
Why?
| Shoulder Dislocation | 1 | 2004 | 48 | 0.060 |
Why?
| Palivizumab | 1 | 2023 | 13 | 0.050 |
Why?
| Acromion | 1 | 2003 | 7 | 0.050 |
Why?
| Arthroplasty | 1 | 2003 | 48 | 0.050 |
Why?
| State Medicine | 1 | 2022 | 18 | 0.050 |
Why?
| Health Services | 1 | 2023 | 103 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2023 | 1690 | 0.050 |
Why?
| Postoperative Complications | 1 | 2012 | 2122 | 0.050 |
Why?
| Psychiatric Nursing | 1 | 2001 | 6 | 0.050 |
Why?
| Dissociative Disorders | 1 | 2001 | 21 | 0.050 |
Why?
| Cadaver | 2 | 2004 | 298 | 0.050 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| Nurse-Patient Relations | 1 | 2001 | 43 | 0.040 |
Why?
| Transcription Factors | 1 | 2008 | 1526 | 0.040 |
Why?
| Vaccines, Attenuated | 1 | 2021 | 113 | 0.040 |
Why?
| Hip Prosthesis | 1 | 2000 | 32 | 0.040 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 47 | 0.040 |
Why?
| Social Networking | 1 | 2020 | 30 | 0.040 |
Why?
| Animals | 2 | 2013 | 31565 | 0.040 |
Why?
| Ultrasonography | 1 | 2003 | 635 | 0.040 |
Why?
| Knee Joint | 1 | 2022 | 322 | 0.040 |
Why?
| Multicenter Studies as Topic | 1 | 2020 | 249 | 0.040 |
Why?
| Nursing Staff, Hospital | 1 | 2001 | 123 | 0.040 |
Why?
| Maternal Age | 1 | 2019 | 116 | 0.040 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 660 | 0.040 |
Why?
| Family | 1 | 2022 | 589 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 27 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 231 | 0.040 |
Why?
| Databases, Factual | 1 | 2023 | 1125 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 60 | 0.040 |
Why?
| Awareness | 1 | 2018 | 93 | 0.040 |
Why?
| Risk Assessment | 3 | 2015 | 2958 | 0.040 |
Why?
| Educational Status | 1 | 2019 | 408 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 25 | 0.040 |
Why?
| Nurse Practitioners | 1 | 2018 | 95 | 0.030 |
Why?
| Accessory Nerve | 1 | 1997 | 3 | 0.030 |
Why?
| Patients | 1 | 2018 | 163 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2018 | 132 | 0.030 |
Why?
| Insurance Coverage | 1 | 2018 | 199 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2017 | 196 | 0.030 |
Why?
| Self Report | 1 | 2020 | 695 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2019 | 571 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1360 | 0.030 |
Why?
| Analysis of Variance | 1 | 2018 | 1218 | 0.030 |
Why?
| Models, Theoretical | 1 | 2019 | 513 | 0.030 |
Why?
| Decision Support Techniques | 1 | 2018 | 336 | 0.030 |
Why?
| Treatment Failure | 1 | 2016 | 330 | 0.030 |
Why?
| Ergonomics | 1 | 2014 | 23 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2384 | 0.030 |
Why?
| Sex Factors | 1 | 2019 | 1706 | 0.030 |
Why?
| Wound Infection | 1 | 2014 | 30 | 0.030 |
Why?
| Prescriptions | 1 | 2014 | 60 | 0.030 |
Why?
| Efficiency | 1 | 2014 | 84 | 0.030 |
Why?
| Occupational Injuries | 1 | 2014 | 46 | 0.030 |
Why?
| Abscess | 1 | 2014 | 70 | 0.030 |
Why?
| Program Evaluation | 1 | 2018 | 820 | 0.030 |
Why?
| Medically Uninsured | 1 | 2014 | 122 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 183 | 0.030 |
Why?
| Mice | 1 | 2008 | 14843 | 0.030 |
Why?
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 76 | 0.020 |
Why?
| Acute Disease | 2 | 2004 | 907 | 0.020 |
Why?
| Biomechanical Phenomena | 2 | 2004 | 669 | 0.020 |
Why?
| Referral and Consultation | 1 | 2014 | 632 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2537 | 0.020 |
Why?
| Orthopedic Procedures | 1 | 2008 | 206 | 0.020 |
Why?
| Palliative Care | 1 | 2011 | 641 | 0.010 |
Why?
| Exercise | 1 | 2014 | 1642 | 0.010 |
Why?
| Rotation | 1 | 2004 | 110 | 0.010 |
Why?
| Posture | 1 | 2004 | 152 | 0.010 |
Why?
| Case-Control Studies | 1 | 2010 | 3003 | 0.010 |
Why?
| Range of Motion, Articular | 1 | 2004 | 350 | 0.010 |
Why?
| Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
| Nursing Methodology Research | 1 | 2001 | 38 | 0.010 |
Why?
| Helping Behavior | 1 | 2001 | 16 | 0.010 |
Why?
| Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| Bone Cements | 1 | 2000 | 35 | 0.010 |
Why?
| Psychological Theory | 1 | 2001 | 94 | 0.010 |
Why?
| Porosity | 1 | 2000 | 88 | 0.010 |
Why?
| Durapatite | 1 | 2000 | 35 | 0.010 |
Why?
| Coated Materials, Biocompatible | 1 | 2000 | 54 | 0.010 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2000 | 107 | 0.010 |
Why?
| Prosthesis Design | 1 | 2000 | 283 | 0.010 |
Why?
| Reoperation | 1 | 2000 | 513 | 0.010 |
Why?
| Social Support | 1 | 2001 | 528 | 0.010 |
Why?
| Survival Analysis | 1 | 2000 | 1206 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|